Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHREE GANESH REMEDIES vs BACIL PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHREE GANESH REMEDIES BACIL PHARMA SHREE GANESH REMEDIES /
BACIL PHARMA
 
P/E (TTM) x 39.0 -90.7 - View Chart
P/BV x 9.6 7.8 123.0% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 SHREE GANESH REMEDIES    BACIL PHARMA
EQUITY SHARE DATA
    SHREE GANESH REMEDIES
Mar-23
BACIL PHARMA
Mar-23
SHREE GANESH REMEDIES /
BACIL PHARMA
5-Yr Chart
Click to enlarge
High Rs34910 3,605.4%   
Low Rs2134 5,809.3%   
Sales per share (Unadj.) Rs70.20-  
Earnings per share (Unadj.) Rs13.2-0.2 -7,648.4%  
Cash flow per share (Unadj.) Rs16.1-0.2 -9,604.8%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.20-  
Book value per share (Unadj.) Rs69.21.9 3,709.3%  
Shares outstanding (eoy) m12.855.89 218.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.00-  
Avg P/E ratio x21.2-38.6 -54.9%  
P/CF ratio (eoy) x17.4-39.6 -43.9%  
Price / Book Value ratio x4.13.6 113.6%  
Dividend payout %3.80-   
Avg Mkt Cap Rs m3,61139 9,185.7%   
No. of employees `000NANA-   
Total wages/salary Rs m391 4,559.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m9020-  
Other income Rs m321 2,752.2%   
Total revenues Rs m9341 81,203.5%   
Gross profit Rs m233-2 -10,971.7%  
Depreciation Rs m370 124,166.7%   
Interest Rs m10 5,800.0%   
Profit before tax Rs m226-1 -22,141.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m560-   
Profit after tax Rs m170-1 -16,686.3%  
Gross profit margin %25.80- 
Effective tax rate %24.60 62,825.3%   
Net profit margin %18.90- 
BALANCE SHEET DATA
Current assets Rs m6432 28,075.1%   
Current liabilities Rs m2370 84,785.7%   
Net working cap to sales %44.90- 
Current ratio x2.78.2 33.1%  
Inventory Days Days60- 
Debtors Days Days1,1300- 
Net fixed assets Rs m7958 10,160.7%   
Share capital Rs m12565 191.7%   
"Free" reserves Rs m764-54 -1,408.0%   
Net worth Rs m88911 8,092.5%   
Long term debt Rs m3090-   
Total assets Rs m1,43710 14,218.5%  
Interest coverage x195.7-50.0 -391.4%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.60-   
Return on assets %11.9-9.9 -120.1%  
Return on equity %19.1-9.3 -206.5%  
Return on capital %18.9-9.1 -207.3%  
Exports to sales %68.60-  
Imports to sales %23.70-  
Exports (fob) Rs m619NA-   
Imports (cif) Rs m213NA-   
Fx inflow Rs m6190-   
Fx outflow Rs m2130-   
Net fx Rs m4050-   
CASH FLOW
From Operations Rs m170-1 -11,572.1%  
From Investments Rs m-536-1 46,185.3%  
From Financial Activity Rs m4131 65,604.8%  
Net Cashflow Rs m48-2 -2,371.6%  

Share Holding

Indian Promoters % 69.3 42.7 162.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.7 57.3 53.5%  
Shareholders   7,518 6,628 113.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHREE GANESH REMEDIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SHREE GANESH REMEDIES vs BACIL PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SHREE GANESH REMEDIES vs BACIL PHARMA Share Price Performance

Period SHREE GANESH REMEDIES BACIL PHARMA S&P BSE HEALTHCARE
1-Day 0.53% 1.95% 1.18%
1-Month -1.72% 43.43% -0.75%
1-Year 176.31% 161.25% 61.82%
3-Year CAGR 35.46% 67.38% 18.16%
5-Year CAGR 75.17% 44.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the SHREE GANESH REMEDIES share price and the BACIL PHARMA share price.

Moving on to shareholding structures...

The promoters of SHREE GANESH REMEDIES hold a 69.3% stake in the company. In case of BACIL PHARMA the stake stands at 42.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SHREE GANESH REMEDIES and the shareholding pattern of BACIL PHARMA.

Finally, a word on dividends...

In the most recent financial year, SHREE GANESH REMEDIES paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 3.8%.

BACIL PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of SHREE GANESH REMEDIES , and the dividend history of BACIL PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.